Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Biology

Cancer Oncology

Engineering

Medicine

Immunology

Show all topics

DOI

10.1186/s12885-024-12574-2

License

CC-BY-NC-ND